Calumet Speciality Products diskutieren
Calumet Speciality Products
WKN: A0H1BP / Symbol: CLMT / Name: Calumet Splty / Aktie / Öl & Gas / Small Cap /
1,94 €
83,02 %
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
Ratings data for CLMT provided by MarketBeat
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) had its price target lowered by analysts at Wells Fargo & Company from $28.00 to $23.00. They now have an "overweight" rating on the stock.
Ratings data for CLMT provided by MarketBeat
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $16.00 to $14.00. They now have a "buy" rating on the stock.
Ratings data for CLMT provided by MarketBeat
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $15.00 price target on the stock.
Ratings data for CLMT provided by MarketBeat
Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) had its price target lowered by analysts at Wells Fargo & Company from $23.00 to $21.00. They now have an "overweight" rating on the stock.
Ratings data for CLMT provided by MarketBeat
Calumet (NASDAQ:CLMT) was given a new $20.00 price target on by analysts at The Goldman Sachs Group, Inc.. They now have a "buy" rating on the stock.
Ratings data for CLMT provided by MarketBeat
Calumet (NASDAQ:CLMT) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $33.00 price target on the stock.
Ratings data for CLMT provided by MarketBeat
Calumet (CLMT) had its price target raised by The Goldman Sachs Group, Inc. from $24.00 to $34.00. They now have a "buy" rating on the stock.
Ratings data for CLMT provided by MarketBeat
Calumet (CLMT) had its price target raised by HC Wainwright from $33.00 to $60.00. They now have a "buy" rating on the stock.
Ratings data for CLMT provided by MarketBeat
Calumet (CLMT) had its "buy" rating reaffirmed by Citigroup Inc..
Ratings data for CLMT provided by MarketBeat
Neueste Beiträge
Barclays_PLC in Discuss Cytokinetics Inc.